Korro Bio, Inc. (KRRO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $186.81M
Last updated: Nov 17, 2026 at 11:06 AM ET
Korro Bio, Inc. (KRRO) Earnings: Report Dates and Results
Korro Bio (KRRO) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, Korro Bio reported EPS of -$0.98, above the -$1.14 estimate. It beat the EPS estimate in 7 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
KRRO has an expected report date of Mar 10, 2027.
Earnings History
Of the 29 quarters below that had an estimate, KRRO beat 17, missed 10 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2023, when EPS landed 986.86% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.98 | -$1.14 | -$2.04 - -$0.93 | +14.04% | Beat | N/A | 10 | 0 up, 1 down | Nov 5, 2026 | N/A |
| Jun 30, 2026 | -$1.07 | -$1.54 | -$2.10 - -$0.66 | +30.52% | Beat | N/A | 9 | 3 up, 2 down | Aug 6, 2026 | N/A |
| Mar 31, 2026 | -$1.69 | -$1.98 | -$3.41 - -$1.31 | +14.73% | Beat | N/A | 5 | 3 up, 0 down | May 7, 2026 | N/A |
| Dec 31, 2025 | -$1.65 | -$2.14 | -$3.19 - -$1.44 | +22.90% | Beat | N/A | 8 | 1 up, 0 down | Mar 12, 2026 | $1.29M |
| Sep 30, 2025 | -$1.92 | -$2.68 | -$3.51 - -$2.40 | +28.36% | Beat | N/A | 8 | 2 up, 6 down | Nov 12, 2025 | $1.09M |
| Jun 30, 2025 | -$2.74 | -$2.59 | -$3.41 - -$2.07 | -5.79% | Miss | N/A | 9 | N/A | Aug 12, 2025 | $1.46M |
| Mar 31, 2025 | -$2.49 | -$2.62 | -$3.14 - -$2.30 | +4.96% | Beat | N/A | 8 | 1 up, 4 down | May 7, 2025 | $2.55M |
| Dec 31, 2024 | -$2.26 | -$2.51 | -$2.90 - -$2.00 | +10.06% | Beat | N/A | 7 | N/A | Mar 18, 2025 | $2.27M |
| Sep 30, 2024 | -$2.26 | -$2.53 | -$2.84 - -$2.40 | +10.67% | Beat | N/A | 5 | 0 up, 0 down | Nov 12, 2024 | N/A |
| Jun 30, 2024 | -$2.43 | -$2.43 | N/A | 0.00% | In line | N/A | N/A | N/A | Aug 13, 2024 | N/A |
| Mar 31, 2024 | -$2.44 | -$2.49 | -$2.54 - -$2.23 | +2.01% | Beat | N/A | 3 | 0 up, 0 down | May 14, 2024 | N/A |
| Dec 31, 2023 | -$25.65 | -$2.36 | -$2.95 - -$1.99 | -986.86% | Miss | N/A | 3 | 0 up, 0 down | Mar 29, 2024 | N/A |
| Sep 30, 2023 | -$15.50 | -$17.73 | N/A | +12.58% | Beat | N/A | N/A | N/A | Nov 2, 2023 | N/A |
| Jun 30, 2023 | -$0.30 | -$0.36 | N/A | +16.67% | Beat | N/A | N/A | N/A | Aug 10, 2023 | N/A |
| Mar 31, 2023 | -$0.55 | -$0.42 | N/A | -30.95% | Miss | N/A | N/A | N/A | May 12, 2023 | N/A |
| Dec 31, 2022 | -$0.49 | -$0.63 | N/A | +22.35% | Beat | N/A | N/A | N/A | Mar 10, 2023 | N/A |
| Sep 30, 2022 | -$0.55 | -$0.57 | N/A | +3.51% | Beat | N/A | N/A | N/A | Dec 29, 2022 | N/A |
| Jun 30, 2022 | -$0.61 | -$0.66 | N/A | +8.04% | Beat | N/A | N/A | N/A | Sep 28, 2022 | N/A |
| Mar 31, 2022 | -$0.67 | -$0.64 | N/A | -5.36% | Miss | N/A | N/A | N/A | Jun 29, 2022 | N/A |
| Dec 31, 2021 | -$0.62 | $0.15 | N/A | -506.02% | Miss | N/A | N/A | N/A | Mar 30, 2022 | N/A |
| Sep 30, 2021 | -$0.73 | -$0.59 | N/A | -23.94% | Miss | N/A | N/A | N/A | Dec 29, 2021 | N/A |
| Jun 30, 2021 | -$0.52 | -$0.51 | N/A | -2.24% | Miss | N/A | N/A | N/A | Sep 28, 2021 | $9.42M |
| Mar 31, 2021 | -$0.60 | $0.14 | N/A | -536.36% | Miss | N/A | N/A | N/A | Jun 28, 2021 | $4.65M |
| Dec 31, 2020 | -$0.30 | -$0.25 | N/A | -18.11% | Miss | N/A | N/A | N/A | Mar 30, 2021 | $9.95M |
| Sep 30, 2020 | -$0.16 | -$0.28 | N/A | +42.34% | Beat | N/A | N/A | N/A | Nov 16, 2020 | $11.25M |
| Jun 30, 2020 | -$0.19 | -$0.19 | N/A | 0.00% | In line | N/A | N/A | N/A | Aug 12, 2020 | $8.52M |
| Mar 31, 2020 | -$0.16 | -$0.17 | N/A | +5.88% | Beat | N/A | N/A | N/A | Jun 29, 2020 | $7.26M |
| Dec 31, 2019 | -$0.19 | $0.10 | N/A | -290.00% | Miss | N/A | N/A | N/A | Mar 30, 2020 | $4.71M |
| Sep 30, 2019 | -$0.73 | -$3.42 | N/A | +78.66% | Beat | N/A | N/A | N/A | Nov 18, 2019 | $24.24M |
| Jun 30, 2019 | -$0.28 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 23, 2019 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$8.80, after -$9.39 the year before. It was -$1.20 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$8.80 | N/A |
| Dec 31, 2024 | -$9.39 | N/A |
| Dec 31, 2023 | -$42.00 | N/A |
| Dec 31, 2022 | -$2.32 | N/A |
| Dec 31, 2021 | -$2.47 | N/A |
| Dec 31, 2020 | -$0.81 | N/A |
| Dec 31, 2019 | -$1.20 | N/A |
Frequently Asked Questions About KRRO
When is Korro Bio's next earnings date?
Korro Bio's next earnings report is expected for Mar 10, 2027.
Did KRRO beat earnings estimates last quarter?
Yes. Korro Bio reported EPS of -$0.98 for the quarter ended Sep 30, 2026, above the -$1.14 estimate, a 14.04% surprise.
What EPS do analysts expect from KRRO next quarter?
The consensus EPS estimate for Korro Bio for the quarter ending Dec 31, 2026 is -$1.38 from 14 analysts, with estimates from -$2.39 to -$0.62.
How often does KRRO beat earnings estimates?
Korro Bio beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +14.97%.
KRRO pages: Overview, Earnings, Forecast, Financials, Competitors